Handbook of HER2-targeted agents in breast cancer (Paperback, 2013 ed.)

Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women worldwide, accounting for nearly a quarter of the total new cancer cases each year. Of these cases, approximately 15-25% overexpress HER2, a transmembrane RTK kinase that is associated with aggressive tumor growth and poor outcomes. However, in the past decade, survival rates of patients with HER-positive breast cancer have significantly improved due to increased screening, HER2 testing, and breakthrough HER2-targeted drug therapies. Handbook of HER2-Targeted Agents in Breast Cancer provides oncologists, primary care physicians, trainees and other healthcare providers with a concise, accessible, and up-to-date survey of the field, including a review of our current understanding of the biology of the HER2 pathway and the rationale for targeting it in early-stage and advanced breast cancer, an overview of HER2-testing, and evidence-based discussions of available HER2-targeted regimens in the adjuvant and metastatic settings.

General

Imprint:	Springer Healthcare
Country of origin:	United Kingdom
Release date:	November 2014
First published:	2013
Authors:	Ricardo H Alvarez • Javier Cortes • Leticia Mattos-Arruda • Mary Falzon • Angelica Fasolo • Michael Gandy • Luca Gianni • Nadia Harbeck • Martine Piccart • Stefania Zambelli
Dimensions:	201 x 127 x 8mm (L x W x T)
Format:	Paperback
Pages:	96
Edition:	2013 ed.
ISBN-13:	978-1-907673-93-1
Categories:	Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General Promotions
LSN:	1-907673-93-8
Barcode:	9781907673931

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!